Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
CGMP AND ATRIAL-NATRIURETIC-FACTOR REGULATE CELL-VOLUME OF RABBIT ATRIAL MYOCYTES
Autore:
CLEMO HF; BAUMGARTEN CM;
Indirizzi:
VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYSIOL RICHMOND VA23298 VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYSIOL RICHMOND VA23298 VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED RICHMOND VA 23298
Titolo Testata:
Circulation research
fascicolo: 4, volume: 77, anno: 1995,
pagine: 741 - 749
SICI:
0009-7330(1995)77:4<741:CAARCO>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
K-CL COTRANSPORT; DEPENDENT PROTEIN-KINASE; VENTRICULAR MYOCYTES; PEPTIDE SECRETION; CULTURED ATRIAL; NITRIC-OXIDE; CHLORIDE CHANNEL; CA2+ CURRENT; HEART; FORSKOLIN;
Keywords:
ATRIAL NATRIURETIC PEPTIDE; CELL VOLUME; NA+/K+/2CL(-) COTRANSPORT; CGMP; PHOSPHODIESTERASE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
55
Recensione:
Indirizzi per estratti:
Citazione:
H.F. Clemo e C.M. Baumgarten, "CGMP AND ATRIAL-NATRIURETIC-FACTOR REGULATE CELL-VOLUME OF RABBIT ATRIAL MYOCYTES", Circulation research, 77(4), 1995, pp. 741-749

Abstract

Atrial natriuretic factor (ANF) reduces the volume of atrial myocytesby inhibiting Na+/K+/2Cl(-) cotransport. We determined the role of cGMP and cAMP in ANF-induced shrinkage by using digital video microscopyto measure cell volume; volumes are reported relative to control. ANF(1 mu mol/L) reversibly reduced atrial cell volume from 1.0 to 0.915+/-0.005 (mean+/-SEM). This effect was mimicked by 10 mu mol/L 8-bromo-cGMP (8-Br-cGMP), which decreased myocyte volume to 0.894+/-0.007 withan ED(50) of 0.99+/-0.05 mu mol/L. In contrast, 100 mu mol/L 8-bromo-cAMP (8-Br-cAMP) did not affect volume, and activating the cAMP pathway with 100 mu mol/L 8-Br-cAMP did not alter the volume decrease causedby 8-Br-cGMP or ANF. Inhibition of Na+/K+/2Cl(-) cotransport with bumetanide (1 mu mol/L) also reduced cell volume and prevented further shrinkage on subsequent exposure to 9-Br-cGMP. Similarly, 8-Br-cGMP (10 mu mol/L) prevented further shrinkage by ANF. Block of Na+-H+ exchange, a participant in volume regulation in other cells, did not alter theresponse to 8-Br-cGMP. More evidence implicating cGMP was obtained byaltering its metabolism. LYS3583 (10 mu mol/L), a guanylate cyclase inhibitor, blocked ANF-induced cell shrinkage. Zaprinast (100 mu mol/L), a cGMP-specific phosphodiesterase inhibitor, markedly potentiated the effect of a threshold concentration of ANF (0.01 mu mol/L). The actions of ANF, LY83583, and zaprinast on cGMP levels were verified by radioimmunoassay. These data strongly support the idea that the cGMP cascade is the intracellular signaling pathway responsible for ANF-inducedatrial cell shrinkage. ANF activates guanylate cyclase, and the subsequent rise in cGMP inhibits Na+/K+/2Cl(-) cotransport. This reduces the uptake of osmolytes, and cell shrinkage follows. In addition, LY83583 caused a small swelling and zaprinast caused a small shrinkage in the absence of other agents. This suggests that physiological levels of cGMP partially inhibit Na+/K+/2Cl(-) cotransport and help set isosmotic cell volume. It is proposed that ANF-induced elevation of atrial cGMP and the ensuing cell shrinkage serve as a negative-feedback mechanism limiting stretch-induced ANF secretion.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/07/20 alle ore 18:10:16